Found 5 matching trials
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
PHASE2Background:
Major depressive disorder (MDD) is a serious mental illness th...
Location
National Institutes of Health Clinical Center
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
PHASE1The goal of this randomized double blind three way (1:1:1) cross over clini...
Location
Rush University Medical Center
Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers
PHASE2Background:
Opioid drugs are often prescribed for acute and chronic pain. ...
Location
National Institutes of Health Clinical Center
Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine
PHASE1A 6-cohort single ascending dose (SAD) study will be conducted in healthy v...
Location
Duke Early Phase Clinical Research
Pilot Study of RR-HNK in OCD
PHASE1The purpose of this study is to understand how RR-HNK works in the brain to...
Location
Stanford University School of Medicine